Robert Vries

Company: HUB Organoids (A Millipore Sigma Company)

Job title: Chief Executive Officer

Seminars:

From Bench to Bedside Faster: How Organoid Platforms Enable Predictive, Scalable, & Ethical Oncology Research 11:15 am

Discover how patient-derived organoid platforms increase the speed and predictive value of preclinical oncology research—enabling early failing and accelerating success with more reliable transitions from discovery to clinical application Learn how scalable, reproducible organoid models address the limitations of cell lines and animal studies by delivering patient-relevant data for drug efficacy, safety, and personalized medicine…Read more

day: Day 2 Track A AM